J, P., M, Q., EJ, C., S, S., JH, M., M, K., . . . KJ, Y. (2026). Patient-derived organoids predict personalized drug response and reveal alternative therapeutic options in glioblastoma. Cell reports. Medicine, 7(7), 102850. https://doi.org/10.1016/j.xcrm.2026.102850
Chicago Style (17th ed.) CitationJ, Park, et al. "Patient-derived Organoids Predict Personalized Drug Response and Reveal Alternative Therapeutic Options in Glioblastoma." Cell Reports. Medicine 7, no. 7 (2026): 102850. https://doi.org/10.1016/j.xcrm.2026.102850.
MLA (9th ed.) CitationJ, Park, et al. "Patient-derived Organoids Predict Personalized Drug Response and Reveal Alternative Therapeutic Options in Glioblastoma." Cell Reports. Medicine, vol. 7, no. 7, 2026, p. 102850, https://doi.org/10.1016/j.xcrm.2026.102850.